New Strong Buy Stocks for March 19th - MSN
| WILYY Stock | USD 18.86 0.03 0.16% |
Slightly above 62% of Demant AS's investor base is looking to short. The analysis of overall sentiment of trading Demant AS ADR pink sheet suggests that many investors are alarmed at this time. Demant AS's investing sentiment can be driven by a variety of factors including economic data, Demant AS's earnings reports, geopolitical events, and overall market trends.
Demant |
New Strong Buy Stocks for March 19th MSN
Read at news.google.com
 |
Demant AS Fundamental Analysis
We analyze Demant AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Demant AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Demant AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Demant AS is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Demant AS ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Demant AS pink sheet to make a market-neutral strategy. Peer analysis of Demant AS could also be used in its relative valuation, which is a method of valuing Demant AS by comparing valuation metrics with similar companies.
Peers
Demant AS Related Equities
| CNMD | CONMED | 4.46 | ||||
| TIVC | Tivic Health | 4.17 | ||||
| HYPR | Hyperfine | 4.08 | ||||
| GNNDY | GN Store | 2.12 | ||||
| APYX | Apyx Medical | 2.11 | ||||
| HSCS | Heart Test | 1.91 | ||||
| INGN | Inogen | 1.85 | ||||
| CHEOY | CochLear | 1.52 | ||||
| BJDX | Bluejay Diagnostics | 0.57 | ||||
| CVRX | CVRx | 0.54 | ||||
| SMMNY | Siemens Healthineers | 0.43 | ||||
| SONVY | Sonova Holding | 0.10 | ||||
| ICAD | Icad | 0.65 | ||||
| AXDX | Accelerate Diagnostics | 1.80 | ||||
| NUWE | Nuwellis | 2.42 | ||||
| GGNDF | GN Store | 15.10 |
Additional Tools for Demant Pink Sheet Analysis
When running Demant AS's price analysis, check to measure Demant AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Demant AS is operating at the current time. Most of Demant AS's value examination focuses on studying past and present price action to predict the probability of Demant AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Demant AS's price. Additionally, you may evaluate how the addition of Demant AS to your portfolios can decrease your overall portfolio volatility.